论文部分内容阅读
目的探讨胺碘酮联合比索洛尔对急性心肌梗死预后及安全性影响。方法收集急性心肌梗死患者100例,平均分为实验组和对照组,实验组患者予以胺碘酮联合比索洛尔治疗,对照组患者予以美托洛尔治疗,比较两组患者的预后情况、心律失常发生情况以及治疗前后QTcd的变化情况。结果实验组患者的各项观察指标明显好于对照组。结论胺碘酮联合比索洛尔可以有效促进急性心肌梗死患者的预后恢复,并且安全可靠。
Objective To investigate the effect of amiodarone combined with bisoprolol on the prognosis and safety of acute myocardial infarction. Methods A total of 100 acute myocardial infarction patients were collected and divided into experimental group and control group. Patients in experimental group were treated with amiodarone and bisoprolol, while patients in control group were treated with metoprolol. The prognosis, heart rate The occurrence of abnormalities and QTcd changes before and after treatment. Results The observation group in the experimental group was significantly better than the control group. Conclusion Amiodarone combined with bisoprolol can effectively promote the prognosis of patients with acute myocardial infarction, and is safe and reliable.